
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Mantle cell lymphoma laboratory findings
Introduction
Overview
Overview
Laboratory tests for mantle cell lymphoma include complete blood count (CBC), comprehensive metabolic panel, LDH levels, Hepatitis B testing if treatment with rituximab is planned, uric acid levels, beta-2-microglobulin, pregnancy testing in woman of child-bearing age, flow cytometry, immunohistochemistry, genetic testing and FISH.
Laboratory tests
Laboratory tests
Laboratory tests for mantle cell lymphoma include:[1]
- Complete blood count (CBC) with differential count
- Pancytopenia or a leukemic presentation with extensive leukocytosis.[2]
- Comprehensive metabolic panel[3]
- LDH levels[4]: Normal range is 100β190 U/L
- Hepatitis B testing if treatment with rituximab is planned[5]
- Uric acid levels: Normal range is 2.4-6.0 mg/dL in females and 3.4-7.0 mg/dL in males.
- Beta-2-microglobulin[6]: Normal range is 0-3 Β΅g/mL.
- Pregnancy testing in woman of child-bearing age
- Flow cytometry
- Immunohistochemistry[7][8]
- Translocation t(11;14)(q13;q32) in virtually all cases
- Mutation or deletions of ATM gene
- FISH (fluorescence in situ hybridization):
- FISH can be used to detect the translocation t(11;14), which is found in most of MCL patients.[10]
References
References
- β https://www.nccn.org/professionals/physician_gls/pdf/b-cell.pdf
- β Ana Ferrer, Itziar Salaverria, Francesc Bosch, Neus Villamor, Maria Rozman, Silvia Bea, Eva Gine, Armando Lopez-Guillermo, Elias Campo & Emili Montserrat (2007). “Leukemic involvement is a common feature in mantle cell lymphoma”. Cancer. 109 (12): 2473β2480. doi:10.1002/cncr.22715. PMIDΒ 17477385. Unknown parameter
|month=ignored (help) - β Julie M. Vose (2017). “Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management”. American journal of hematology. 92 (8): 806β813. doi:10.1002/ajh.24797. PMIDΒ 28699667. Unknown parameter
|month=ignored (help) - β Julie M. Vose (2017). “Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management”. American journal of hematology. 92 (8): 806β813. doi:10.1002/ajh.24797. PMIDΒ 28699667. Unknown parameter
|month=ignored (help) - β Arturo Ciccullo, F. R. Ponziani, E. Maiolo, F. Pallavicini & M. Pompili (2018). “Late reactivation of hepatitis B virus after rituximab-containing chemotherapy for mantle cell lymphoma: a case report”. Infection. doi:10.1007/s15010-018-1242-1. PMIDΒ 30368733. Unknown parameter
|month=ignored (help) - β Julie M. Vose (2017). “Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management”. American journal of hematology. 92 (8): 806β813. doi:10.1002/ajh.24797. PMIDΒ 28699667. Unknown parameter
|month=ignored (help) - β Francesco Bertoni, Emanuele Zucca & Finbarr E. Cotter (2004). “Molecular basis of mantle cell lymphoma”. British journal of haematology. 124 (2): 130β140. PMIDΒ 14687022. Unknown parameter
|month=ignored (help) - β Chan Yoon Cheah, John F. Seymour & Michael L. Wang (2016). “Mantle Cell Lymphoma”. Journal of clinical oncologyΒ : official journal of the American Society of Clinical Oncology. 34 (11): 1256β1269. doi:10.1200/JCO.2015.63.5904. PMIDΒ 26755518. Unknown parameter
|month=ignored (help) - β Jordi Camps, Itziar Salaverria, Maria J. Garcia, Esther Prat, Silvia Bea, Jessica C. Pole, Lluis Hernandez, Javier Del Rey, Juan Cruz Cigudosa, Marta Bernues, Carlos Caldas, Dolors Colomer, Rosa Miro & Elias Campo (2006). “Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines”. Leukemia research. 30 (8): 923β934. doi:10.1016/j.leukres.2005.11.013. PMIDΒ 16448697. Unknown parameter
|month=ignored (help) - β Tsieh Sun, Mary Lowery Nordberg, James D. Cotelingam, Diana M. Veillon & John Ryder (2003). “Fluorescence in situ hybridization: method of choice for a definitive diagnosis of mantle cell lymphoma”. American journal of hematology. 74 (1): 78β84. doi:10.1002/ajh.10356. PMIDΒ 12949897. Unknown parameter
|month=ignored (help)
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]
